Auxly Cannabis Group Inc (CBWTF)

[europa7]

Analyzing Auxly Cannabis' Financial Projections
By Margaret Patrick Dec 20, 2018 | 5:45 AM
https://marketrealist.com/2018/12/analyzing-auxly-cannabis-financial-projections

Revenue and EBITDA projections

Auxly Cannabis (CBWTF) is expected to report revenues of 4.34 million Canadian dollars in fiscal 2018. Analysts expect the company to report revenues of 165.33 million Canadian dollars in fiscal 2019, which is a YoY (year-over-year) rise of 3,709.49%. The company is also expected to report revenues of 569.38 million Canadian dollars in fiscal 2020, which is a YoY rise of 244.39%.

Analysts expect Auxly Cannabis to report an EBITDA of -24.79 million Canadian dollars in fiscal 2018. However, the company is expected to report an EBITDA of 35.19 million Canadian dollars in fiscal 2019, which is a YoY rise of 241.91%. The company is also expected to report an EBITDA of 204.41 million Canadian dollars in fiscal 2020, which is a YoY rise of 480.87%
Net income and EPS projections

Analysts expect Auxly Cannabis to report a net income of -43.61 million Canadian dollars in fiscal 2018. The company is expected to turn profitable in fiscal 2019 and report a net income of 10.63 million Canadian dollars, which is a YoY rise of 124.37%. The company is also expected to report a net income of 130.13 million Canadian dollars in fiscal 2020, which is a YoY rise of 1,124.20%.

Analysts expect Auxly Cannabis to report an EPS of -0.09 Canadian dollars in fiscal 2018. The company is expected to report an EPS of 0.02 Canadian dollars in fiscal 2019, which is a YoY rise of 122.22%. The company is also expected to report an EPS of 0.18 Canadian dollars in fiscal 2020, which is a YoY rise of 800.00%.
Analysts’ recommendations

Analysts’ 12-month consensus recommendation for Auxly Cannabis stock trading on the Toronto Stock Exchange on December 19 is a “strong buy.” The company’s target price has been set at 3.00 Canadian dollars, which is a rise of 476.92% compared to the last closing price of 0.52 Canadian dollars on the Toronto Stock Exchange. Currently, only one analyst is covering the stock. The analyst recommended a “strong buy” rating.

cheers...